Longer times from symptom onset to randomization equaled a smaller—or perhaps no—advantage for Impella vs standard care.

Please provide your email address to receive an email when new articles are posted on . Risk for death was lower with the pump vs. standard care only, but incidence of adverse events was elevated. The ...

Impella, which J&J touts as the world’s smallest heart pump, has a range of devices used for various heart conditions. Lexeo ...

Implantation of the Impella CP micro-axial flow pump in the hours after a heart attack significantly increased the rate of survival at six months among people suffering cardiogenic shock, according to ...

After demonstrating last year that its miniaturized heart pumps could improve survival shortly after a serious heart attack, Johnson & Johnson MedTech has now shown that the benefits from its Impella ...

Please provide your email address to receive an email when new articles are posted on . Abiomed is recalling specific Impella 5.5 left ventricular device systems due to product leakage. The FDA ...

Collaboration will combine Lexeo expertise in cardiac genetic medicine with Johnson & Johnson’s expertise in cardiovascular ...

The Impella heart pump is a small pump that a healthcare professional can insert without surgery. It can help maintain blood flow in people who have CAD, are recovering from cardiogenic shock, or are ...

An FDA alert warned of Abiomed's Automated Impella Controller potentially not detecting an Impella pump when connected. The BMI-breast cancer link appeared especially strong in postmenopausal women ...